Migraine clinical trials at UCSF
1 in progress, 1 open to new patients
open to eligible people ages 10–17
This will be a randomized, multi-site double-blind placebo-controlled trial of melatonin (2 different dosing arms) vs. placebo for migraine prevention in adolescents. We intend to enroll approximately 210 participants over 15 months at two sites: UCLA and UCSF. The duration of participation for each participant will be 4 months.
San Francisco, California and other locations